P1456: EARLY SAFETY AND CLINICAL COURSE OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MEASURABLE RESIDUAL DISEASE RECEIVING GTA002, AN OFF-THE-SHELF, EX VIVO-CULTURED ALLOGENEIC NK CELL PREPARATION
M. Heuser,
W. Fiedler,
A. Block,
D. C. de Leeuw,
A. van de Loosdrecht,
A. Astrid Tschan-Plessl,
J. Passweg,
A. Kloos,
A. Schwarzer,
L. Venturini,
A. D. Duru,
K. Pinkernell,
A. Ganser
Affiliations
M. Heuser
1 Department for Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover
W. Fiedler
2 II. Medizinische Klinik und Poliklinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
A. Block
2 II. Medizinische Klinik und Poliklinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
D. C. de Leeuw
3 Department of Hematology, Amsterdam University Medical Center, Amsterdam, Netherlands
A. van de Loosdrecht
3 Department of Hematology, Amsterdam University Medical Center, Amsterdam, Netherlands
A. Astrid Tschan-Plessl
4 Clinical and Diagnostic Hematology, University Hospital Basel, Basel, Switzerland
J. Passweg
4 Clinical and Diagnostic Hematology, University Hospital Basel, Basel, Switzerland
A. Kloos
1 Department for Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover
A. Schwarzer
5 Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany
L. Venturini
1 Department for Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover
A. D. Duru
6 Glycostem Therapeutics, Oss, Netherlands
K. Pinkernell
6 Glycostem Therapeutics, Oss, Netherlands
A. Ganser
1 Department for Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover
